These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3300292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG, Vanderniepen P, Bossuyt AM, Jonckheer MH, Six RO.
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F, Gregianin M, Bui F, Macrì C, Folino P, Mantero F.
    Eur J Clin Pharmacol; 1991 Aug; 40(3):309-11. PubMed ID: 1676368
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL, Vukovich RA, Dennick LG, Groel JT, Willard DA.
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [Abstract] [Full Text] [Related]

  • 8. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG, Laher MS, McGarry K, O'Brien E, O'Malley K.
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED, Messerli FH, Deslinski GR, Kobrin I.
    Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME, Glazer N, Wollam G, Zager PG, Cangiano J.
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM, Shaker A, Ramadan M, Hamza S, Tadros SS.
    J Int Med Res; 1980 Jul; 8(3):193-8. PubMed ID: 6104614
    [Abstract] [Full Text] [Related]

  • 18. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
    O'Connor DT, Barg AP, Duchin KL.
    J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP, Van Buskirk EM, Shields MB.
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.